Source: Annual Congress 2009 - PG15 The complexity of COPD: assessment and advanced therapies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Cazzola (Rome, Italy). Assessing the effect of medical therapy in COPD: from pathophysiology and biomarkers to clinical practice. Annual Congress 2009 - PG15 The complexity of COPD: assessment and advanced therapies

Member's Comments

No comment yet.

Related content which might interest you: Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019 Year: 2020 COPD management in Swedish clinical practice Source: Annual Congress 2007 - Primary care management of COPD Year: 2007 COPD treatment from pathophysiology to clinical trials Source: ERS Live 2007 Year: 2007 Guidelines versus clinical practice in the treatment of COPD: a reappraisal Source: Eur Respir J 2006; 27: 656 Year: 2006 Implementation of questionnaires in the management of COPD patients in clinical practice Source: Annual Congress 2013 –PG18 Assessing the health status and quality of life in asthma and COPD patients Year: 2013 Implementation of questionnaires in the management of asthma patients in clinical practice Source: Annual Congress 2013 –PG18 Assessing the health status and quality of life in asthma and COPD patients Year: 2013 Emerging concepts in outcome assessment for COPD clinical trials Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease Year: 2007 The relevance of small-airways dysfunction for patients and doctors in daily clinical management Source: Annual Congress 2013 –Small airways in asthma: from physiologic measures to clinical relevance Year: 2013 An audit of COPD: diagnosis and management in general practice Source: ERJ Open Res, 6 (4) 00330-2020; 10.1183/23120541.00330-2020 Year: 2020 What is the scientific and clinical rationale? Triple therapy in COPD patients Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what? Year: 2021 Towards individualised medicine for airways disease: identifying clinical phenotype groups Source: Eur Respir J 2012; 39: 1033-1034 Year: 2012 Evaluation of the use of e-learning in training management of asthma and COPD in general medicine. Source: International Congress 2017 – Medical education, web and internet Year: 2017 A critical evaluation of the relevance of different asthma phenotypes for clinical practice Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium Year: 2008 The disease model: implications for clinical practice Source: Eur Respir J, 51 (4) 1800188; 10.1183/13993003.00188-2018 Year: 2018 COPD: algorithms and clinical management Source: Eur Respir J, 50 (5) 1701733; 10.1183/13993003.01733-2017 Year: 2017 Assessment of the COPD patients’ care: An audit of clinical practice Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations Year: 2013 The role of the practice nurse in the management of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 328s Year: 2001 Effects of pharmacist interventions to inhalation medication adherence and lung functions in COPD patients at one stop service clinic Source: International Congress 2014 – COPD exacerbations Year: 2014 Integrating patients with respiratory and cardiac disease in one rehabilitation programme: clinical outcomes of a pragmatic service evaluation. Source: International Congress 2019 – Innovations in care for chronic respiratory conditions Year: 2019